{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Multiple+Diseases&page=42", "query": { "condition": "Multiple Diseases", "page": 42 }, "page_size": 10 }, "pagination": { "page": 42, "page_size": 10, "total_count": 12236, "total_pages": 1224, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Multiple+Diseases&page=43&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Multiple+Diseases&page=41&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-13T02:53:11.893Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01445899", "title": "PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Choroidal Neovascularization", "Diabetic Retinopathy", "Diabetic Macular Edema" ], "interventions": [ { "name": "PF-04523655 (Stratum I)", "type": "DRUG" }, { "name": "ranibizumab", "type": "DRUG" }, { "name": "PF-04523655 (Stratum II)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Quark Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 258, "start_date": "2012-02", "completion_date": "2013-11", "has_results": false, "last_update_posted_date": "2015-02-23", "last_synced_at": "2026-11-13T02:53:11.893Z", "location_count": 20, "location_summary": "Phoenix, Arizona • Arcadia, California • Beverly Hills, California + 17 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Arcadia", "state": "California" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Campbell", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01445899" }, { "nct_id": "NCT04009187", "title": "A Wheelchair Propulsion Training Program", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Spinal Cord Injuries", "Multiple Sclerosis", "Amputation", "Spina Bifida" ], "interventions": [ { "name": "In-person wheelchair propulsion training program", "type": "BEHAVIORAL" }, { "name": "30-minute education session", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 20, "start_date": "2018-03-27", "completion_date": "2019-10-22", "has_results": false, "last_update_posted_date": "2025-03-28", "last_synced_at": "2026-11-13T02:53:11.893Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT04009187" }, { "nct_id": "NCT01016314", "title": "Efficacy of the Aspen Spinous Process System in Anterior Lumbar Interbody Fusion (ALIF)", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Degenerative Disc Disease" ], "interventions": [ { "name": "Aspen Spinous Process System", "type": "DEVICE" }, { "name": "Pedicle Screw Fixation", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Zimmer Biomet", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 0, "start_date": "2009-11", "completion_date": "2016-01", "has_results": false, "last_update_posted_date": "2019-01-23", "last_synced_at": "2026-11-13T02:53:11.893Z", "location_count": 5, "location_summary": "Pomona, California • Sacramento, California • Kansas City, Kansas + 2 more", "locations": [ { "city": "Pomona", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Kansas City", "state": "Kansas" }, { "city": "New York", "state": "New York" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01016314" }, { "nct_id": "NCT05003804", "title": "Allergic Disease Onset Prevention Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Atopic Dermatitis", "Type 1 Hypersensitivity" ], "interventions": [ { "name": "STMC-103H", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Siolta Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "0 Days", "maximum_age": "14 Days", "sex": "ALL", "summary": "0 Days to 14 Days" }, "enrollment_count": 283, "start_date": "2021-09-01", "completion_date": "2025-10-21", "has_results": false, "last_update_posted_date": "2025-11-20", "last_synced_at": "2026-11-13T02:53:11.893Z", "location_count": 24, "location_summary": "Tucson, Arizona • Little Rock, Arkansas • Los Angeles, California + 19 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05003804" }, { "nct_id": "NCT00585507", "title": "Efficacy and Safety of 500mg of Fulvestrant", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "Fulvestrant", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Beth Israel Deaconess Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 40, "start_date": "2004-04", "completion_date": "2027-03-15", "has_results": false, "last_update_posted_date": "2026-05-22", "last_synced_at": "2026-11-13T02:53:11.893Z", "location_count": 5, "location_summary": "Boston, Massachusetts • Lowell, Massachusetts • South Weymouth, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Lowell", "state": "Massachusetts" }, { "city": "South Weymouth", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00585507" }, { "nct_id": "NCT03823534", "title": "Post-Op Pain Control for Prophylactic Intramedullary Nailing.", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bone Metastases", "Lymphoma", "Multiple Myeloma", "Opioid Use", "Pain" ], "interventions": [ { "name": "Ketorolac", "type": "DRUG" }, { "name": "Normal saline", "type": "DRUG" }, { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Oxycodone Acetaminophen", "type": "DRUG" }, { "name": "Morphine", "type": "DRUG" }, { "name": "Hydrocodone/Acetaminophen", "type": "DRUG" }, { "name": "Oxycodone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "St. Louis University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2019-02-20", "completion_date": "2027-03-31", "has_results": false, "last_update_posted_date": "2026-04-22", "last_synced_at": "2026-11-13T02:53:11.893Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT03823534" }, { "nct_id": "NCT01718899", "title": "Phase 1/2a Study of Cancer Vaccine to Treat Smoldering Multiple Myeloma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Smoldering Multiple Myeloma" ], "interventions": [ { "name": "PVX-410", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "OncoPep, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "95 Years", "sex": "ALL", "summary": "18 Years to 95 Years" }, "enrollment_count": 22, "start_date": "2012-11", "completion_date": "2016-09", "has_results": false, "last_update_posted_date": "2016-09-28", "last_synced_at": "2026-11-13T02:53:11.893Z", "location_count": 6, "location_summary": "Atlanta, Georgia • Niles, Illinois • Boston, Massachusetts + 1 more", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Niles", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01718899" }, { "nct_id": "NCT00793793", "title": "Safety, Antiviral Activity and PK of MRD of BI 201335 in Chronic Hepatitis C Patients Both Treatment Naive and -Experienced", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hepatitis C, Chronic" ], "interventions": [ { "name": "BI201335", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 96, "start_date": "2007-09", "completion_date": "2011-01-25", "has_results": true, "last_update_posted_date": "2018-09-05", "last_synced_at": "2026-11-13T02:53:11.893Z", "location_count": 6, "location_summary": "San Francisco, California • Baltimore, Maryland • New York, New York + 1 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00793793" }, { "nct_id": "NCT02207621", "title": "Evaluation of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma and Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ocular Hypertension", "Open-angle Glaucoma" ], "interventions": [ { "name": "AR-13324 Ophthalmic Solution 0.02%", "type": "DRUG" }, { "name": "Timolol maleate Ophthalmic Solution 0.5% BID", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" }, { "name": "AR-13324 Ophthalmic Solution 0.02% BID", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Aerie Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "99 Years", "sex": "ALL", "summary": "Up to 99 Years" }, "enrollment_count": 756, "start_date": "2014-07", "completion_date": "2016-03", "has_results": true, "last_update_posted_date": "2018-04-06", "last_synced_at": "2026-11-13T02:53:11.893Z", "location_count": 1, "location_summary": "Bedminster, New Jersey", "locations": [ { "city": "Bedminster", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT02207621" }, { "nct_id": "NCT01746030", "title": "Geriatric Assessments in Senior Adults With Multiple Myeloma", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Multiple Myeloma" ], "interventions": [], "intervention_types": [], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 42, "start_date": "2012-09", "completion_date": "2015-07", "has_results": false, "last_update_posted_date": "2015-11-20", "last_synced_at": "2026-11-13T02:53:11.893Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT01746030" } ] }